ADC Therapeutics.
company in Épalinges, Switzerland
- Reports this week
- 0
- Active events
- 0
- Connections
- 18
What's happening
Earlier this month
One to three months ago
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
What's reaching ADC Therapeutics
Events traced to ADC Therapeutics, step by step, newest first- ADC Therapeutics may benefit from reduced competition in wet AMD treatmentADC Therapeutics may benefit from reduced competition in wet AMD treatment.Possible
- Nxera's APAC expansion may intensify competition for ADC TherapeuticsNxera's APAC expansion may intensify competition for ADC TherapeuticsPossible
Around ADC Therapeutics this week
News at the entities that move ADC Therapeutics most-
FDA StructuralPresident Boakai is addressed by community petitions, and Rudolph Merab is named as the Managing Director of the FDA.Moves ADC Therapeutics
-
European Commission StructuralAndy Burnham will hold talks with the European Commission and Council regarding a trade deal expected to boost GDP and ease food and youth mobility.Moves ADC Therapeutics
-
Nasdaq Shared contextAnthropic debuted on Nasdaq, while Andrew Benson spoke to CNN about Hill's share tracking services.Moves ADC Therapeutics
-
London Shared contextMP Catherine advocates for funding to curb air pollution in London.Moves ADC Therapeutics
-
New Jersey Shared contextConnolly Dermatology reopened several locations across New Jersey and Delaware and filed a lawsuit in Atlantic County.Moves ADC Therapeutics
-
Italy Shared contextSweden and Italy increased funding for democracy defenders on November 20, 2026.Moves ADC Therapeutics
Connections
The 14 strongest of 18, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
ADC Therapeutics' drug development and commercial status are fundamentally governed by regulatory actions and approvals from the FDA.
-
European Commission Structural
ADC Therapeutics' product ZYNLONTA received conditional approval and is regulated by the European Commission.
-
Mohamed Zaki Structural
Mohamed Zaki serves as the Chief Medical Officer for ADC Therapeutics.
-
American Society of Hematology Operational
ADC Therapeutics presented data at a meeting organized by the American Society of Hematology.
-
Lugano Shared context
ADC Therapeutics conducts research and presentations in Lugano, utilizing local criteria for response assessment.
-
Nasdaq Shared context
ADC Therapeutics is listed and trades on the Nasdaq market platform.
-
London Shared context
ADC Therapeutics maintains operational presence within London.
-
Nxera Pharma Operational
The companies are actively competing in the market, as evidenced by direct comparisons of their financial and market performance.
Show all 14 connections
-
New Jersey Shared context
ADC Therapeutics maintains operational presence within the state of New Jersey.
-
Italy Shared context
ADC Therapeutics conducts clinical trials and presents data within Italy.
-
Switzerland Shared context
ADC Therapeutics is a company based and operating within Switzerland.
-
Milan Shared context
ADC Therapeutics conducts clinical trials and presents data within Milan.
-
Lausanne Shared context
ADC Therapeutics is headquartered in Lausanne.
-
LinkedIn Operational
ADC Therapeutics utilizes LinkedIn for professional outreach.